User profiles for M. Mannis
Mark MannisUniversity of California, Davis, Dept of Ophthalmology & Vision Science Verified email at ucdavis.edu Cited by 13988 |
Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee
In 2002, the National Rosacea Society assembled an expert committee to develop the first
standard classification of rosacea. This original classification was intended to be updated as …
standard classification of rosacea. This original classification was intended to be updated as …
The IC3D classification of the corneal dystrophies
Background: The recent availability of genetic analyses has demonstrated the shortcomings
of the current phenotypic method of corneal dystrophy classification. Abnormalities in …
of the current phenotypic method of corneal dystrophy classification. Abnormalities in …
Contact lenses in the management of keratoconus
The range of contact lens modalities currently available for the successful optical correction
of keratoconus is greatly expanded. We review lens types currently available for the …
of keratoconus is greatly expanded. We review lens types currently available for the …
[BOOK][B] Cornea e-book
JH Krachmer, MJ Mannis, EJ Holland - 2010 - books.google.com
Cornea, edited by Drs. Krachmer, Mannis & Holland, is the only truly comprehensive clinical
reference available that covers external disease, anterior uveitis, and the expanding range …
reference available that covers external disease, anterior uveitis, and the expanding range …
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel
…, M Mannis, HH Oon, M Rajagopalan… - British journal of …, 2017 - academic.oup.com
Background Rosacea is currently diagnosed by consensus‐defined primary and secondary
features and managed by subtype. However, individual features (phenotypes) can span …
features and managed by subtype. However, individual features (phenotypes) can span …
Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel
…, M Mannis, HH Oon, M Rajagopalan… - British Journal of …, 2017 - academic.oup.com
Background Rosacea is currently treated according to subtypes. As this does not adequately
address the spectrum of clinical presentation (phenotypes), it has implications for patient …
address the spectrum of clinical presentation (phenotypes), it has implications for patient …
Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea
We find that substance P (SP) and insulin‐like growth factor‐1 (IGF‐1) demonstrate a
synergistic effect on the stimulation of rabbit corneal epithelial migration in an organ culture. The …
synergistic effect on the stimulation of rabbit corneal epithelial migration in an organ culture. The …
Intraocular lens power calculation after laser in situ keratomileusis for myopia and hyperopia: a standardized approach
V Feiz, MJ Mannis, F Garcia-Ferrer, G Kandavel… - Cornea, 2001 - journals.lww.com
Purpose. (1) To determine the effect of myopic and hyperopic laser in situ keratomileusis (LASIK)
on calculation of intraocular lens (IOL) power.(2) To determine a standard way to …
on calculation of intraocular lens (IOL) power.(2) To determine a standard way to …
Defensins are mitogenic for epithelial cells and fibroblasts
… The leukocytes were resuspended in 0.34 M sucrose (pH 7.4) and homogenized in a glass
teflon pestle homogenizer. Cell debris and unbroken cells were removed by another low-…
teflon pestle homogenizer. Cell debris and unbroken cells were removed by another low-…
Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis
MA Greiner, JY Li, MJ Mannis - Ophthalmology, 2011 - Elsevier
PURPOSE: To evaluate retention of visual acuity and development of complications after
Boston type 1 keratoprosthesis implantation over a longer follow-up period than previously …
Boston type 1 keratoprosthesis implantation over a longer follow-up period than previously …